Ambea AB (AMBEA) Fair Value & Analysis
Healthcare · SE · Market cap 11.4B SEK
Analysis
Ambea AB (AMBEA) currently trades at kr 133.20, while our model-based Fair Value estimate is kr 182.00 — implying the stock looks roughly 36.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The company offers social care services; schools for children and youth with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services for elderly people under the Vardaga brand; and social care for adults, children, and youth, as well as personal assistance under the Stendi brand. It also offers disability care, nursing home, home care, and rehabilitation services under the Altiden brand. In addition, the company offers staff solutions for social welfare services, including ambulatory care teams and student health service staffing under the Klara brand. Further, it develops and offers skills development training and coaching services in disability care, social services field, aged care, and schools under the Lära brand; and …
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.